Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Thursday evening:

Caterpillar (CAT - Get Report): “Even though Caterpillar’s probably not going to have a good quarter, I don’t mind owning it.”

Facebook (FB - Get Report): “They can earn $3.15 per share in 2017, which can take the stock to $100.”

Alcoa (AA - Get Report): “We’re waiting for the company to get into more titanium and aircraft businesses -- waiting for the RTI acquisition to close.”

Juno Therapeutics (JUNO): “High-risk, speculative biotech; but it’s not bad as long as you understand the risk.”

Cypress Semiconductor (CY - Get Report): “The stock’s been disappointing despite some great acquisitions. I want you to stick with it, though.”

Kite Pharma (KITE): “Another speculative play, but I like BlueBird Bio (BLUE - Get Report) instead.”

Citigroup (C - Get Report): “Citigroup is a buy.”

Rexx Energy (REXX): “We want to be in oil stocks, which are undervalued, not natural gas.”

Insys Therapeutics (INSY): “It’s real and it’s good. This is a good company.”

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

 

At the time of publication, Cramer's Action Alerts PLUS had a position in FB.